Siolta Therapeutics to Present Phase 2 ADORED Trial Results at AAAAI 2026 Siolta Therapeutics will present its findings from the Phase 2 ADORED trial during AAAAI 2026, showcasing promising results in at-risk infants.

Siolta Therapeutics to Present Phase 2 ADORED Trial Results at AAAAI 2026 #USA #Philadelphia #Siolta_Therapeutics #STMC-103H #ADORED_trial